Bettina C. Urban
BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling
Urban, Bettina C.; Collard, Tracey J.; Eagle, Catherine J.; Southern, Samantha L.; Greenhough, Alexander; Hamdollah-Zadeh, Maryam; Ghosh, Anil; Poulsom, Richard; Paraskeva, Christos; Silver, Andrew; Williams, Ann C.
Authors
Tracey J. Collard
Catherine J. Eagle
Samantha L. Southern
Alexander Greenhough Alexander.Greenhough@uwe.ac.uk
Associate Professor of Health Diagnostics
Maryam Hamdollah-Zadeh
Anil Ghosh
Richard Poulsom
Christos Paraskeva
Andrew Silver
Ann C. Williams
Abstract
Objective Colorectal cancer remains the fourth most common cause of cancer-related mortality worldwide. Here we investigate the role of nuclear factor-?B (NF-?B) co-factor B-cell CLL/lymphoma 3 (BCL-3) in promoting colorectal tumour cell survival. Design Immunohistochemistry was carried out on 47 tumour samples and normal tissue from resection margins. The role of BCL-3/NF-?B complexes on cell growth was studied in vivo and in vitro using an siRNA approach and exogenous BCL-3 expression in colorectal adenoma and carcinoma cells. The question whether BCL-3 activated the AKT/protein kinase B (PKB) pathway in colorectal tumour cells was addressed by western blotting and confocal microscopy, and the ability of 5- aminosalicylic acid (5-ASA) to suppress BCL-3 expression was also investigated. Results We report increased BCL-3 expression in human colorectal cancers and demonstrate that BCL-3 expression promotes tumour cell survival in vitro and tumour growth in mouse xenografts in vivo, dependent on interaction with NF-?B p50 or p52 homodimers. We show that BCL-3 promotes cell survival under conditions relevant to the tumour microenvironment, protecting both colorectal adenoma and carcinoma cells from apoptosis via activation of the AKT survival pathway: AKT activation is mediated via both PI3K and mammalian target of rapamycin (mTOR) pathways, leading to phosphorylation of downstream targets GSK- 3 and FoxO1/3a. Treatment with 5-ASA suppressed BCL-3 expression in colorectal cancer cells. Conclusions Our study helps to unravel the mechanism by which BCL-3 is linked to poor prognosis in colorectal cancer; we suggest that targeting BCL-3 activity represents an exciting therapeutic opportunity potentially increasing the sensitivity of tumour cells to conventional therapy.
Citation
Urban, B. C., Collard, T. J., Eagle, C. J., Southern, S. L., Greenhough, A., Hamdollah-Zadeh, M., …Williams, A. C. (2016). BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling. Gut, 65(7), 1151-1164. https://doi.org/10.1136/gutjnl-2014-308270
Journal Article Type | Article |
---|---|
Acceptance Date | Mar 21, 2015 |
Online Publication Date | Jun 1, 2015 |
Publication Date | Jul 1, 2016 |
Deposit Date | Feb 12, 2019 |
Publicly Available Date | Mar 28, 2024 |
Journal | Gut |
Print ISSN | 0017-5749 |
Electronic ISSN | 1468-3288 |
Publisher | BMJ Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 65 |
Issue | 7 |
Pages | 1151-1164 |
DOI | https://doi.org/10.1136/gutjnl-2014-308270 |
Public URL | https://uwe-repository.worktribe.com/output/910367 |
Publisher URL | https://doi.org/10.1136/gutjnl-2014-308270 |
Files
Urban_Gut_2016.pdf
(3.9 Mb)
PDF
You might also like
Interacting proteins, polymorphisms and the susceptibility of animals to SARS-CoV-2
(2021)
Journal Article
Downloadable Citations
About UWE Bristol Research Repository
Administrator e-mail: repository@uwe.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search